These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The corporate assault on the Food and Drug Administration. Nixon R. Int J Health Serv; 1996 Aug; 26(3):561-8. PubMed ID: 8840203 [Abstract] [Full Text] [Related]
13. Senate FDA reform bill--good news for the pharmaceutical industry? Jack DB. Mol Med Today; 1995 Oct 08; 1(7):300. PubMed ID: 9415166 [No Abstract] [Full Text] [Related]
14. ASHP response to FDA reform. Wallace ML. Am J Health Syst Pharm; 1996 Sep 01; 53(17):2089-90. PubMed ID: 8870899 [No Abstract] [Full Text] [Related]
16. Medicaid, FDA reform key issues building steam in Congress. Gatty B. Formulary; 1995 May 01; 30(5):294, 293. PubMed ID: 10151729 [No Abstract] [Full Text] [Related]
17. Coming closer to FDA reform. Cimmons M. Nat Med; 1997 Sep 01; 3(9):940. PubMed ID: 9288707 [No Abstract] [Full Text] [Related]
18. Can the US congress slow down and get FDA reform right? Robbins A. Lancet; 2007 May 12; 369(9573):1583-4. PubMed ID: 17499585 [No Abstract] [Full Text] [Related]
20. Perspectives. Approval process a moving target in FDA reform hearings. Rhein R. Faulkner Grays Med Health; 1996 Feb 19; 50(8):suppl 1-4. PubMed ID: 10154482 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]